{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:42:44Z","timestamp":1793731364910,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.transproceed.2020.01.158","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:58:28Z","timestamp":1589140708000},"page":"1749-1756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed Using a Systematic Surveillance and Treatment Strategy"],"prefix":"10.1016","volume":"52","author":[{"given":"Seunghwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.01.158_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-6143.2002.020106.x","article-title":"Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation","volume":"2","author":"Hirsch","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","article-title":"The decade of polyomavirus BK-associated nephropathy: state of affairs","volume":"87","author":"Ramos","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1681\/ASN.V1051080","article-title":"Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease","volume":"10","author":"Nickeleit","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2020.01.158_bib4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM200005043421802","article-title":"Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy","volume":"342","author":"Nickeleit","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2020.01.158_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2020.01.158_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib9","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2020.01.158_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.12998\/wjcc.v7.i3.270","article-title":"Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation","volume":"7","author":"Favi","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.transproceed.2020.01.158_bib11","first-page":"165","article-title":"Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN","volume":"34","author":"Pollara","year":"2011","journal-title":"New Microbiol"},{"issue":"Suppl. 4","key":"10.1016\/j.transproceed.2020.01.158_bib12","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1111\/j.1600-6143.2009.02904.x","article-title":"BK virus in solid organ transplant recipients","volume":"9","author":"Hirsch","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.transproceed.2020.01.158_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1600-6143.2012.03993.x","article-title":"The Banff 2009 working proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome","volume":"12","author":"Masutani","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/01.TP.0000107040.70217.B3","article-title":"Polyomavirus nephropathy: what have we learned?","volume":"77","author":"Mannon","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.transproceed.2020.01.158_bib18","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1600-6143.2008.02402.x","article-title":"Polyomavirus BK replication dynamics in\u00a0vivo and in silico to predict cytopathology and viral clearance in kidney transplants","volume":"8","author":"Funk","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jcv.2009.12.006","article-title":"Human polyoma viruses and disease with emphasis on clinical BK and JC","volume":"47","author":"Boothpur","year":"2010","journal-title":"J\u00a0Clin Virol"},{"issue":"Suppl. 3","key":"10.1016\/j.transproceed.2020.01.158_bib20","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1432-2277.2012.01480.x","article-title":"Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy","volume":"25","author":"Chung","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2020.01.158_bib22","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.transproceed.2013.08.044","article-title":"Monitoring and treatment for BK virus after kidney transplantation","volume":"45","author":"Moon","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.158_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/tid.12153","article-title":"Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor","volume":"16","author":"H\u00e4ssig","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2020.01.158_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.23876\/j.krcp.2018.37.2.167","article-title":"Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients","volume":"37","author":"Park","year":"2018","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.transproceed.2020.01.158_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/TP.0000000000001066","article-title":"Viral origin, clinical course, and renal outcomes in patients with BK virus infection after living-donor renal transplantation","volume":"100","author":"Schwarz","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib26","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","article-title":"Clinical course of polyoma virus nephropathy in 67 renal transplant patients","volume":"13","author":"Ramos","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2020.01.158_bib27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1432-2277.2009.00842.x","article-title":"Treatment for BK virus: incidence, risk factors, and outcomes for kidney transplant recipients in the United States","volume":"22","author":"Schold","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2020.01.158_bib29","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5002247","article-title":"Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender","volume":"71","author":"Khamash","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2020.01.158_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOT.0000000000000101","article-title":"BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions","volume":"19","author":"Pham","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/TP.0b013e3182a6890d","article-title":"CMV viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation","volume":"96","author":"Elfadawy","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ndt\/18.2.397","article-title":"CMV infection of the renal allograft is much more common than the pathology indicates: a retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR","volume":"18","author":"Liapis","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.TP.0000437671.78716.f3","article-title":"Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab","volume":"97","author":"Barbosa","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib34","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/TP.0b013e3181dc0999","article-title":"Evaluation of low-dose rituximab induction therapy in living related kidney transplantation","volume":"89","author":"Takagi","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib35","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/TP.0b013e3181726849","article-title":"ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up","volume":"85","author":"Genberg","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/TP.0b013e3181bca422","article-title":"Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs","volume":"88","author":"Egli","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2369-14-207","article-title":"BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition","volume":"14","author":"Jacobi","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2020.01.158_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/ctr.12151","article-title":"Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience","volume":"27","author":"Moscarelli","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12659\/AOT.882640","article-title":"BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes?","volume":"17","author":"Acott","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2020.01.158_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2215\/CJN.08420813","article-title":"Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation","volume":"9","author":"Elfadawy","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2020.01.158_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/TP.0b013e31825a505d","article-title":"Factors influencing viral clearing and renal function during polyomavirus BK-associated nephropathy after renal transplantation","volume":"94","author":"Schwarz","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1086\/605538","article-title":"From plasma BK viral load to allograft damage: rule of thumb for estimating the intrarenal cytopathic wear","volume":"49","author":"Funk","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2020.01.158_bib43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/TP.0b013e31816a33d4","article-title":"Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study","volume":"85","author":"Alm\u00e9ras","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib44","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/TP.0b013e318166cba8","article-title":"Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy","volume":"85","author":"Saad","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.158_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/vim.2007.0030","article-title":"Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults","volume":"20","author":"Zhou","year":"2007","journal-title":"Viral Immunol"},{"key":"10.1016\/j.transproceed.2020.01.158_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transproceed.2020.01.158_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.idc.2010.02.003","article-title":"Viral impact on long-term kidney graft function","volume":"24","author":"Helanter\u00e4","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.transproceed.2020.01.158_bib48","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2215\/CJN.05691207","article-title":"Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies","volume":"3","author":"Weiss","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519318299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519318299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:35:03Z","timestamp":1758576903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519318299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0041134519318299"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.158","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed Using a Systematic Surveillance and Treatment Strategy","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}